NWBI:NASDAQNorthwest Bancshares, Inc. Analysis
Data as of 2026-06-14 - not real-time
$14.80
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The stock is trading just below its 52‑week high with the 20‑day SMA comfortably above the 50‑day and 200‑day averages, confirming a short‑term bullish alignment. Momentum indicators reinforce this view: the MACD line sits above its signal, the histogram remains positive, and the RSI is perched near the upper threshold, suggesting the price may be approaching overbought territory. Volume has been tapering, and 30‑day volatility is approaching 20%, while the fear‑and‑greed index signals extreme greed, indicating that market enthusiasm is high but may be vulnerable to a pullback.
Fundamentally, the bank delivered a record net income for the quarter, outpacing revenue expectations with double‑digit growth and strong operating margins. The forward P/E is well below the trailing multiple, the dividend yield exceeds 5% with a payout ratio near 90%, and the company has authorized a buyback, underscoring confidence in cash generation. However, the DCF‑derived fair value trails the current price by a modest margin, and the high dividend payout warrants monitoring of cash flow sustainability.
Fundamentally, the bank delivered a record net income for the quarter, outpacing revenue expectations with double‑digit growth and strong operating margins. The forward P/E is well below the trailing multiple, the dividend yield exceeds 5% with a payout ratio near 90%, and the company has authorized a buyback, underscoring confidence in cash generation. However, the DCF‑derived fair value trails the current price by a modest margin, and the high dividend payout warrants monitoring of cash flow sustainability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance and overbought RSI
- Decreasing volume amid high volatility
- Attractive dividend yield providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Quarterly earnings beat and record net income
- Forward P/E discount to trailing multiple
- Buyback authorization and strong dividend yield
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustainable dividend with solid cash flow
- Low beta indicating defensive profile
- Consistent loan growth and stable earnings outlook
Key Metrics & Analysis
Financial Health
Revenue Growth15.10%
Profit Margin21.41%
P/E Ratio16.1
ROE7.53%
ROA0.85%
P/B Ratio1.1
Op. Cash Flow$119.7M
Industry P/E16.8
Technical Analysis
TrendBullish
RSI68.8
Support$13.32
Resistance$14.80
MA 20$14.08
MA 50$13.77
MA 200$12.74
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value$12.09
Target Price$15.00
Upside/Downside1.39%
GradeFair
TypeBlend
Dividend Yield5.41%
Risk Assessment
Beta0.65
Volatility19.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.